E for L Aim Public Company Limited

SET:EFORL Stock Report

Market Cap: ฿1.1b

E for L Aim Valuation

Is EFORL undervalued compared to its fair value, analyst forecasts and its price relative to the market?

Valuation Score

4/6

Valuation Score 4/6

  • Below Fair Value

  • Significantly Below Fair Value

  • Price-To-Sales vs Peers

  • Price-To-Sales vs Industry

  • Price-To-Sales vs Fair Ratio

  • Analyst Forecast

Share Price vs Fair Value

What is the Fair Price of EFORL when looking at its future cash flows? For this estimate we use a Discounted Cash Flow model.

Below Fair Value: EFORL (THB0.28) is trading below our estimate of fair value (THB1.26)

Significantly Below Fair Value: EFORL is trading below fair value by more than 20%.

Key Valuation Metric

Which metric is best to use when looking at relative valuation for EFORL?

Key metric: As EFORL is barely profitable we use its Price-To-Sales Ratio for relative valuation analysis.

The above table shows the Price to Sales ratio for EFORL. This is calculated by dividing EFORL's market cap by their current revenue.
What is EFORL's PS Ratio?
PS Ratio0.9x
Sales฿1.22b
Market Cap฿1.12b

Price to Sales Ratio vs Peers

How does EFORL's PS Ratio compare to its peers?

The above table shows the PS ratio for EFORL vs its peers. Here we also display the market cap and forecasted growth for additional consideration.
CompanyForward PSEstimated GrowthMarket Cap
Peer Average1.3x
SMD SaintMed
1.5xn/a฿1.2b
BIZ Business Alignment
1.2xn/a฿2.1b
BIS Bioscience Animal Health
0.5xn/a฿1.1b
SEI SEI Medical
2x21.0%฿846.6m
EFORL E for L Aim
0.9xn/a฿1.1b

Price-To-Sales vs Peers: EFORL is good value based on its Price-To-Sales Ratio (0.9x) compared to the peer average (1.3x).

Price to Sales Ratio vs Industry

How does EFORL's PS Ratio compare vs other companies in the TH Healthcare Industry?

0 CompaniesPrice / SalesEstimated GrowthMarket Cap
No more companies available in this PS range
EFORL 0.9xIndustry Avg. 2.0xNo. of Companies9PS01.22.43.64.86+
0 CompaniesEstimated GrowthMarket Cap
No more companies

Price-To-Sales vs Industry: EFORL is good value based on its Price-To-Sales Ratio (0.9x) compared to the TH Healthcare industry average (2x).

Price to Sales Ratio vs Fair Ratio

What is EFORL's PS Ratio compared to its Fair PS Ratio? This is the expected PS Ratio taking into account the company's forecast earnings growth, profit margins and other risk factors.

EFORL PS Ratio vs Fair Ratio.
Fair Ratio
Current PS Ratio0.9x
Fair PS Ration/a

Price-To-Sales vs Fair Ratio: Insufficient data to calculate EFORL's Price-To-Sales Fair Ratio for valuation analysis.

Analyst Price Targets

What is the analyst 12-month forecast and do we have any statistical confidence in the consensus price target?

Analyst Forecast: Insufficient data to show price forecast.

Discover undervalued companies

Master Style

฿12.7b

Operates a cosmetic surgery hospital under the Masterpiece Hospital name in Thailand.

MASTER

฿42.25

7D

-8.2%

1Y

-7.1%

E for L Aim

฿1.1b

Engages in the distribution of medical devices and equipment in Thailand.

EFORL-R

฿0.28

7D

3.7%

1Y

12.0%

Safe Fertility Group

฿3.6b

Provides fertility medical center services in Thailand.

SAFE

฿12.00

7D

-0.8%

1Y

-33.0%